Close Menu

In this week's PNAS Early Edition, an international research team led by investigators at the Chung-Ang University College of Medicine in Seoul describe how it induced self-renewal in human somatic progenitor cells in an efficient, safe, and therapeutically effective manner with one "regulatable gene," v-myc. The team created "induced conditional self-renewing progenitor cells" by introducing v-myc via a Tet-on gene expression system.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.